Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Outcome of Younger Adults with Philadelphia Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL) in First Relapse: A Graall Study

Blood (2014) 124 (21): 931.

https://doi.org/10.1182/blood.V124.21.931.931

Published: 2014

Journal Articles

Secondary Malignancies After Autologous Stem Cell Transplantation In Patients With Relapsed / Refractory Hodgkin´s Lymphoma. A Retrospective Analysis On Behalf Of The Lymphoma Working Party Of The European Society For Blood and Marrow Transplantation (EBMT)

Anna Sureda, MD, Ariane Boumendil, PhD, Michal Sieniawski, MD, Kirsty Thomson, MD, Martin Gramatzki, MD, Didier Blaise, Catherine Thieblemond, MD, Charles Crawley, MD, Marc Renaud, MD, Patrice Chevalier, MD, Jian Jian Luan, Kim H. Orchard, MD, Paneesha Shankara, MD, Urs Schanz, MD, Norbert Schmitz, Peter Dreger, MD

Blood (2013) 122 (21): 4636.

https://doi.org/10.1182/blood.V122.21.4636.4636

Published: 2013

Journal Articles

Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients Aged ≥60 Years: a Retrospective Study of 629 Patients From the Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC).

Blood (2009) 114 (22): 194.

https://doi.org/10.1182/blood.V114.22.194.194

Published: 2009

Journal Articles

Unrelated Cord Blood Transplantation (UCBT) in Adults with MDS or Secondary Acute Myeloblastic Leukemia (sAML): a Survey On Behalf of Eurocord and CLWP of EBMT.

Marie Robin, MD, Guillermo Sanz, Irina Ionescu, Bernard Rio, Anne Sirvent, Marc Renaud, MD, Enric Carreras, MD, PhD, Noel-Jean Milpied, MD, T. M. de Witte, Alessandra Picardi, MD, Eliane Gluckman, Nicolaus Kroger, Vanderson Rocha

Blood (2009) 114 (22): 1198.

https://doi.org/10.1182/blood.V114.22.1198.1198

Published: 2009

Journal Articles

The Use of Bone Marrow Graft for Hematopoietic Stem Cell Transplantation From Matched Unrelated Donors After Reduced Intensity Conditioning Regimen Improves Survival : Analysis of the Societe Française De Greffe De Moelle Et De Therapie Cellulaire.

Andrea Toma, Marie-Lorraine Balère-Appert, Jean-Michel Boiron, MD, Pierre Bordigoni, Pr, Gerard Socie, MD, PhD, Jean-Paul Vernant, Pr, Marc Renaud, MD, Noel Milpied, MD, PhD, Mauricette Michallet, MD, PhD, Eric Deconinck, Pr, Denis Guyotat, MD, PhD, Frederic Garban, MD, Anne Sirvent, MD, Nathalie Contentin, MD, Didier Blaise, Pr, Evelyne Marry, Agnes Buzyn, Pr

Blood (2009) 114 (22): 873.

https://doi.org/10.1182/blood.V114.22.873.873

Published: 2009

Journal Articles

Double Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation: French Society of Bone Marrow Graft Transplantation and Cellular Therapy Experience

Jacques-Olivier Bay, Aurelie Cabrespine-Faugeras, Reza Tabrizi, Pierre Bordigoni, Karin Bilger, Marc Renaud, Valerie Mialou, Marie Robin, Mathieu Kuentz, Patrice Chevallier, Nathalie Dhedin, Jean-Yves Cahn, Michel Attal, Didier Blaise, Mauricette Michallet

Blood (2008) 112 (11): 4293.

https://doi.org/10.1182/blood.V112.11.4293.4293

Published: 2008

Journal Articles

Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation (RIC allo-SCT) for Patients with High-Risk Multiple Myeloma (MM): A Survey from the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire.

Mohamad Mohty, MD, PhD, Le Quoc-Hung, Franck E Nicolini, MD, PhD, Frederic Garban, MD, Gerard Socie, Michel Attal, MD, Noel- Jean Milpied, PhD, Bruno Lioure, MD, Pierre Bordigoni, MD, Ibrahim Yakoub-Agha, MD, PhD, Jean-Henri Bourhis, Bernard Rio, Eric Deconinck, Marc Renaud, MD, Jean-Luc Harousseau, Didier Blaise, MD, Mauricette Michallet, MD

Blood (2008) 112 (11): 2165.

https://doi.org/10.1182/blood.V112.11.2165.2165

Published: 2008

Journal Articles

Double Cord Blood Cell (CBC) Hematopoietic Stem Cell Transplantation after Standard or Reduced Intensity Conditioning: Report of the SFGMTC Registry.

Blood (2008) 112 (11): 1972.

https://doi.org/10.1182/blood.V112.11.1972.1972

Published: 2008

Journal Articles

KIR-Ligand Incompatibility in the Graft-Versus-Host Direction Is Associated with Better Outcomes after Unrelated Cord Blood Stem Cell Transplantation for Acute Leukemia in Complete Remission

Blood (2008) 112 (11): 156.

https://doi.org/10.1182/blood.V112.11.156.156

Published: 2008

Journal Articles

Unrelated Cord Blood Transplantation after Reduced Intensity Conditioning (RIC) in Adults with Hematological Malignancy. An EBMT-Eurocord-Netcord, Société Française de Greffe de Moelle et de Thérapie Cellulaire and University of Minnesota Collaborative Study.

Vanderson Rocha, MD, Bernard Rio, MD, Claudio Brunstein, MD, Marc Renaud, MD, Attilio Olivieri, MD, Anne Sirvent, MD, Reza Tabrizi, MD, Madalina Uzunov, MD, Karim Boudjedir, MD, Irina Ionescu, MD, Celso A. Rodrigues, MD, Eliane Gluckman, MD, Didier Blaise, MD, John E. Wagner, MD

Blood (2007) 110 (11): 2027.

https://doi.org/10.1182/blood.V110.11.2027.2027

Published: 2007

Journal Articles

Cord Blood Transplantation from Unrelated Donors for Adults with Advanced Lymphoid Malignancies - A Eurocord-Netcord Group/EBMT-LWP Study.

Celso A. Rodrigues, MD, Claudio Brunstein, MD, Guillermo Sanz, MD, Marc Renaud, MD, Marcos de Lima, MD, Didier Blaise, MD, Bernard Rio, MD, Adrienne B.M. Madureira, MD, Anna Sureda, MD, John E. Wagner, MD, Eliane Gluckman, MD, Vanderson Rocha, MD

Blood (2007) 110 (11): 2025.

https://doi.org/10.1182/blood.V110.11.2025.2025

Published: 2007

Journal Articles

Updated Analysis of Allogeneic HSCT after RIC for Hematological Malignancies from the Société Française de Greffe de Moelle Osseuse et de Thérapie Cellulaire (SFGM-TC) Registry.

Mauricette Michallet, MD, PhD, Quoc-Hung Le, MD, Mohamad Mohty, MD, PhD, Franck E. Nicolini, MD, PhD, Jean-Michel Boiron, MD, Hélène Espérou, MD, Michel Attal, MD, PhD, Noel Milpied, MD, Bernard Lioure, MD, Pierre Bordigoni, MD, Ibrahim Yackoub-Agha, MD, PhD, Jean-Henri Bourhis, MD, PhD, Bernard Rio, MD, Eric Deconninck, MD, Marc Renaud, MD, Mohamad Sobh, PhD, Nicole Raus, Didier Blaise, MD

Blood (2007) 110 (11): 1085.

https://doi.org/10.1182/blood.V110.11.1085.1085

Published: 2007

Journal Articles

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome

Blood (2007) 109 (8): 3489–3495.

https://doi.org/10.1182/blood-2006-08-040410

Published: 2007

Includes: Supplemental data

Journal Articles

Reduced Intensity Conditioning Regimen in Single Unrelated Cord Blood Transplantation in Adults with Hematological Malignant Disorders. An Eurocord-Netcord and SFGM-TC Survey.

Vanderson Rocha, MD, PhD, Bernard Rio, MD, Federico Garnier, MD, Marc Renaud, MD, Anne Sirvent, MD, Satoshi Takahashi, MD, Didier Blaise, MD, Eliane Gluckman, MD

Blood (2006) 108 (11): 3143.

https://doi.org/10.1182/blood.V108.11.3143.3143

Published: 2006

Journal Articles

Impact of HLA Allele Mismatch on the Outcome of Patients with Reduced-Intensity Allogeneic Haematopoietic Stem Cell Transplantation from Unrelated Donors: Analysis of 103 Patients of the French Registry.

Andrea Toma, Marie-Lorraine Balere-Appert, Zina Chir, Jean-Michel Boiron, Pierre Bordigoni, Gerard Socie, Jean-Paul Vernant, Marc Renaud, Noel-Jean Milpied, Mauricette Michallet, Eric Deconninck, Denis Guyotat, Frederic Garban, Anne Sirvent, Nathalie Contentin, Didier Blaise, Colette Raffoux, Agnes Buzyn

Blood (2006) 108 (11): 3149.

https://doi.org/10.1182/blood.V108.11.3149.3149

Published: 2006

Journal Articles

No Evidence for Increased Transplant Related Complications in Ph+ Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia with Prior Treatment with Dasatinib.

Merav Leiba, MD, Avichai Shimoni, MD, Francois Guilhot, MD, Geraldine Martineau, MD, Marc Renaud, MD, Sylvie Francois, MD, Izhar Hardan, MD, Arnon Nagler, MD

Blood (2006) 108 (11): 2975.

https://doi.org/10.1182/blood.V108.11.2975.2975

Published: 2006

Journal Articles

Maintenance therapy with thalidomide improves survival in patients with multiple myeloma

Blood (2006) 108 (10): 3289–3294.

https://doi.org/10.1182/blood-2006-05-022962

Published: 2006

Journal Articles

Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy

Blood (2006) 107 (4): 1292–1298.

https://doi.org/10.1182/blood-2005-04-1588

Published: 2006

Journal Articles

Maintenance Treatment with Thalidomide after Autologous Transplantation for Myeloma: Final Analysis of a Prospective Randomized Study of the “Intergroupe Francophone du Myelome”.

Blood (2005) 106 (11): 1148.

https://doi.org/10.1182/blood.V106.11.1148.1148

Published: 2005

Journal Articles

Reduced Intensity Conditioning Regimen for Unrelated Cord Blood Transplantation in Adults. A Multicentric Phase I-II Trial.

Bernard Rio, MD, Ramdane Belhocine, MD, Marc Renaud, MD, Sylvie François, MD, Eliane Gluckman, MD, Didier Blaise, MD, Vanderson Rocha, MD, PhD

Blood (2005) 106 (11): 3658.

https://doi.org/10.1182/blood.V106.11.3658.3658

Published: 2005

NARROW

Outcome of Younger Adults with Philadelphia Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL) in First Relapse: A Graall Study

Secondary Malignancies After Autologous Stem Cell Transplantation In Patients With Relapsed / Refractory Hodgkin´s Lymphoma. A Retrospective Analysis On Behalf Of The Lymphoma Working Party Of The European Society For Blood and Marrow Transplantation (EBMT)

Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients Aged ≥60 Years: a Retrospective Study of 629 Patients From the Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC).

Unrelated Cord Blood Transplantation (UCBT) in Adults with MDS or Secondary Acute Myeloblastic Leukemia (sAML): a Survey On Behalf of Eurocord and CLWP of EBMT.

The Use of Bone Marrow Graft for Hematopoietic Stem Cell Transplantation From Matched Unrelated Donors After Reduced Intensity Conditioning Regimen Improves Survival : Analysis of the Societe Française De Greffe De Moelle Et De Therapie Cellulaire.

Double Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation: French Society of Bone Marrow Graft Transplantation and Cellular Therapy Experience

Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation (RIC allo-SCT) for Patients with High-Risk Multiple Myeloma (MM): A Survey from the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire.

Double Cord Blood Cell (CBC) Hematopoietic Stem Cell Transplantation after Standard or Reduced Intensity Conditioning: Report of the SFGMTC Registry.

KIR-Ligand Incompatibility in the Graft-Versus-Host Direction Is Associated with Better Outcomes after Unrelated Cord Blood Stem Cell Transplantation for Acute Leukemia in Complete Remission

Unrelated Cord Blood Transplantation after Reduced Intensity Conditioning (RIC) in Adults with Hematological Malignancy. An EBMT-Eurocord-Netcord, Société Française de Greffe de Moelle et de Thérapie Cellulaire and University of Minnesota Collaborative Study.

Cord Blood Transplantation from Unrelated Donors for Adults with Advanced Lymphoid Malignancies - A Eurocord-Netcord Group/EBMT-LWP Study.

Updated Analysis of Allogeneic HSCT after RIC for Hematological Malignancies from the Société Française de Greffe de Moelle Osseuse et de Thérapie Cellulaire (SFGM-TC) Registry.

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome

Reduced Intensity Conditioning Regimen in Single Unrelated Cord Blood Transplantation in Adults with Hematological Malignant Disorders. An Eurocord-Netcord and SFGM-TC Survey.

Impact of HLA Allele Mismatch on the Outcome of Patients with Reduced-Intensity Allogeneic Haematopoietic Stem Cell Transplantation from Unrelated Donors: Analysis of 103 Patients of the French Registry.

No Evidence for Increased Transplant Related Complications in Ph+ Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia with Prior Treatment with Dasatinib.

Maintenance therapy with thalidomide improves survival in patients with multiple myeloma

Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy

Maintenance Treatment with Thalidomide after Autologous Transplantation for Myeloma: Final Analysis of a Prospective Randomized Study of the “Intergroupe Francophone du Myelome”.

Reduced Intensity Conditioning Regimen for Unrelated Cord Blood Transplantation in Adults. A Multicentric Phase I-II Trial.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only